SG Americas Securities’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,320
| Closed | -$53K | – | 2776 |
|
|
2024
Q1 | $53K | Buy |
+11,320
| New | +$53K | ﹤0.01% | 2427 |
|
|
2022
Q4 | – | Sell |
-40,890
| Closed | -$1.51M | – | 2934 |
|
|
2022
Q3 | $1.51M | Buy |
40,890
+20,218
| +98% | +$749K | 0.02% | 615 |
|
|
2022
Q2 | $393K | Sell |
20,672
-84,145
| -80% | -$1.6M | ﹤0.01% | 1967 |
|
|
2022
Q1 | $2.83M | Sell |
104,817
-49,633
| -32% | -$1.34M | 0.02% | 597 |
|
|
2021
Q4 | $3.48M | Buy |
154,450
+147,653
| +2,172% | +$3.33M | 0.02% | 616 |
|
|
2021
Q3 | $178K | Buy |
+6,797
| New | +$178K | ﹤0.01% | 3045 |
|
|
2021
Q1 | – | Sell |
-17,034
| Closed | -$546K | – | 2998 |
|
|
2020
Q4 | $546K | Sell |
17,034
-44,919
| -73% | -$1.44M | ﹤0.01% | 1684 |
|
|
2020
Q3 | $2.33M | Buy |
61,953
+54,281
| +708% | +$2.04M | 0.01% | 517 |
|
|
2020
Q2 | $343K | Buy |
+7,672
| New | +$343K | ﹤0.01% | 2075 |
|